290660.Kq

The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.34, indicating a conservative approach to leverage. Despite this, the company's liquidity position is assessed as low, with a current ratio of 2.28, suggesting that it may face challenges in meeting short-term obligations. The company's cash and equivalents amount to 32,876,857,860 KRW, which is a significant portion of its total assets, but its operating cash flow is negative at -232,757,030 KRW, indicating ongoing cash flow challenges.

Profitability metrics reveal a concerning trend, with a return on equity of -0.2306 and a return on assets of -0.1581, both significantly below the industry median for the Advanced Medical Equipment & Technology sector. The company reported a net loss of 12,297,443,130 KRW and an operating loss of 3,365,789,230 KRW, which is a clear deviation from the typical performance of its peers. These figures suggest that the company is not currently generating returns that meet the expectations of its investors or the industry benchmarks.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification could expose the company to higher risks if market conditions in its primary operating region deteriorate. The absence of detailed segment or geographic breakdowns in the available data limits the ability to assess the full extent of its exposure.

The company's growth trajectory is currently negative, with a net loss and declining operating cash flow. The outlook for the current fiscal year does not indicate a reversal of this trend, and there are no disclosed plans or initiatives that suggest a path to profitability in the near term. The company's capital expenditures of -2,203,942,290 KRW further indicate a reduction in investment, which may hinder future growth.

Risk factors include the company's negative net income and operating income, which could lead to increased financial distress and potentially impact its credit rating. The risk assessment indicates a low probability of dilution, but the company's negative free cash flow of -11,664,803,910 KRW suggests that it may need to raise additional capital in the future, which could result in share dilution. The company has not disclosed any recent events or filings that would indicate a significant change in its risk profile.

Recent events and filings do not show any material changes in the company's operations or financial condition. The company has not issued any new products or services that would significantly alter its revenue streams or competitive position. The absence of recent events or filings suggests a stable but stagnant business environment for the company.